58,929 Shares in Bath & Body Works, Inc. $BBWI Purchased by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 58,929 shares of the company’s stock, valued at approximately $1,363,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Parallel Advisors LLC grew its holdings in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the period. State of Michigan Retirement System boosted its position in shares of Bath & Body Works by 1.2% in the 1st quarter. State of Michigan Retirement System now owns 49,300 shares of the company’s stock worth $920,000 after purchasing an additional 600 shares during the last quarter. Meeder Asset Management Inc. grew its stake in shares of Bath & Body Works by 28.5% during the fourth quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after purchasing an additional 637 shares during the period. State of Wyoming increased its stake in shares of Bath & Body Works by 6.2% in the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock valued at $338,000 after acquiring an additional 661 shares during the last quarter. Finally, Vident Advisory LLC raised its position in shares of Bath & Body Works by 2.8% in the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock valued at $756,000 after acquiring an additional 692 shares during the period. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $19.40 on Monday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The business has a fifty day moving average price of $20.37 and a two-hundred day moving average price of $20.16. The stock has a market capitalization of $3.91 billion, a PE ratio of 5.45, a P/E/G ratio of 1.92 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. During the same period last year, the firm posted $0.49 earnings per share. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities analysts expect that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date is Friday, August 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 22.47%.

Analyst Ratings Changes

A number of research firms have issued reports on BBWI. Piper Sandler started coverage on Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price for the company. UBS Group decreased their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. TD Cowen boosted their target price on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Finally, Telsey Advisory Group decreased their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a report on Thursday, May 28th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $21.93.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.